Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kite Pharma
Pharma
Gilead's Kite exits China cell therapy JV with Fosun Pharma
Kite’s exit from the Fosun JV comes as CAR-T meds continue to navigate patient access and reimbursement dynamics in China.
Angus Liu
Sep 19, 2024 4:23pm
Kite will evaluate Cellares' cell therapy manufacturing platform
Jun 27, 2024 8:00am
Cytiva rolls out new CAR-T manufacturing platform
May 30, 2024 9:19am
Gilead's Kite shortens Yescarta manufacturing time with FDA nod
Jan 30, 2024 8:39am
FDA wants classwide boxed warning on existing CAR-Ts
Jan 23, 2024 3:27am
Gilead calls off Oceanside biologics expansion, moves team north
Jan 16, 2024 4:14pm
